Cardlytics, Inc. (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 6,464 Shares

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) insider Nicholas Hollmeyer Lynton sold 6,464 shares of the business’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $23,722.88. Following the transaction, the insider now owns 91,771 shares in the company, valued at approximately $336,799.57. This represents a 6.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Cardlytics Stock Performance

Shares of CDLX stock opened at $3.35 on Thursday. The company’s fifty day moving average price is $3.89 and its 200-day moving average price is $4.77. The stock has a market cap of $170.25 million, a PE ratio of -0.55 and a beta of 1.53. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics, Inc. has a 12 month low of $2.89 and a 12 month high of $20.52.

Cardlytics (NASDAQ:CDLXGet Free Report) last announced its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The business had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. During the same quarter last year, the firm earned ($0.26) earnings per share. The business’s revenue for the quarter was down 15.1% on a year-over-year basis. On average, equities analysts expect that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CDLX. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research note on Thursday, November 7th. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Finally, Evercore ISI initiated coverage on shares of Cardlytics in a research report on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price for the company. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $6.92.

Read Our Latest Stock Analysis on CDLX

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CDLX. Bank of New York Mellon Corp raised its position in shares of Cardlytics by 15.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 135,924 shares of the company’s stock worth $1,116,000 after purchasing an additional 18,179 shares during the last quarter. Quest Partners LLC lifted its stake in shares of Cardlytics by 160.4% in the second quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock worth $147,000 after buying an additional 11,061 shares in the last quarter. ClariVest Asset Management LLC grew its holdings in shares of Cardlytics by 48.7% during the second quarter. ClariVest Asset Management LLC now owns 72,546 shares of the company’s stock valued at $596,000 after buying an additional 23,746 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of Cardlytics by 711.9% during the second quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock valued at $2,882,000 after acquiring an additional 307,800 shares in the last quarter. Finally, Pekin Hardy Strauss Inc. purchased a new position in Cardlytics in the 2nd quarter worth approximately $243,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.